Please assess the completion status of the following clinical trial:

Trial Title: Evaluation of the Efficacy and Safety of Administering Lidocaine Spray in Oesophago-gastro-duodenoscopy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion criteria:~* Patients aged over 18~* ASA I, II and III~* Non allergic to lidocaine or any of the drugs used in the study~* Consent form signed by the patient~Exclusion Criteria:~* Stomach or esophagus diagnosed cancer~* Giant hiatal hernia diagnosed~* Zenker's diverticulum diagnosed~* Achalasia diagnosed~* Patients aged over 70~* Medical history of moderate to severe liver disease~* Medical history of moderate to severe renal insufficiency~* Medical history of moderate to severe Obstructive Sleep Apnea Syndrome (OSA) (AHI≥15).~* Severe respiratory insufficiency(asmtha or COPD) diagnosed~* Patients with encephalopaty active~* Patients with medical history of methemoglobinemia~* Patients with history of drug abuse~* Patients with mental impairment~* Patients with BMI≥ 35~* Use of pediatric tube

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Study Arms:
- Lidocaine (Type: EXPERIMENTAL): Five lidocaine solution puffs (10mg lidocaine/puff) on the four posterior quadrants of the pharynx and on the base of the tongue, 3 minutes before the oesophago-gastro-duodenoscopy.
- Control (Type: PLACEBO_COMPARATOR): Five placebo solution puffs on the four posterior quadrants of the pharynx and on the base of the tongue, 3 minutes before the oesophago-gastro-duodenoscopy

Based on this trial design, predict the completion outcome and termination type (if applicable).